COSA 2020: Encorafenib + Cetuximab ± Binimetinib Improves OS and ORR in Previously Treated BRAF V600E - Mutated mCRC
Updated survival results were reported.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.